Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Japan Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20081
20091
20111
20124
20135
20142
20151
20161
20173
20185
20192
20218
20226
20232
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting12
Recruiting11
Terminated5
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
Eli Lilly and Company6
Pfizer6
Novartis Pharmaceuticals4
AbbVie2
Australasian Gastro-Intestinal Trials Group2
BeiGene2
Daiichi Sankyo2
Japan Clinical Oncology Group2
ARCAGY/ GINECO GROUP1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis55
Breast Neoplasms17
Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Carcinoma6
Colorectal Neoplasms4
Neoplasms by Site4
Breast Diseases3
Prostatic Neoplasms3
Skin Diseases3

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.